RSS-Feed abonnieren

DOI: 10.1055/s-0044-1788686
Evaluating the Efficacy of Resveratrol-Containing Mouthwash as an Adjunct Treatment for Periodontitis: A Randomized Clinical Trial
Authors

Abstract
Objectives To evaluate the effectiveness of resveratrol mouthwash as an adjunct to nonsurgical periodontal treatment of periodontitis.
Materials and Methods This study was a randomized, double-blind clinical trial study. The study included 57 participants with periodontitis. Clinical parameters (plaque index [PI], bleeding on probing [BOP], probing pocket depth [PPD], and clinical attachment loss [CAL]) were examined at the baseline visit, after 7 days, and after 30 days of using resveratrol mouthwash as an adjunct to nonsurgical periodontal treatment. The salivary levels of (interleukin [IL]-6) and RANKL (receptor activator of nuclear factor-kappa B ligand) were measured and compared before and after treatment. The participants answered the visual analog scale-based assessment questionnaire at the last visit.
Statistical Analysis A one-way ANOVA (analysis of variance) test was used to compare the means of multiple groups (test, positive control, negative control) at baseline and after treatment. A paired t-test was also used to compare the means of a single group before and after treatment. In addition, Tukey's multiple comparisons test was used to identify specific pairwise differences between the three groups after finding significant differences with ANOVA. The Chi-square test was also used to compare the distribution of categorical variables like sex between the groups.
Results All interventions significantly reduced PI, BOP, PPD, and CAL, but resveratrol and chlorhexidine had a higher significant effect than placebo except for CAL without a significant difference between them. All mouthwashes significantly reduced the salivary concentration of IL-6. However, resveratrol and chlorhexidine had a significantly higher effect than placebo, while the concentration of RANKL was decreased in all groups without a significant difference between them. The participants' responses to the mouthwash questionnaire showed that resveratrol and chlorhexidine had the same feedback without significant differences.
Conclusion Resveratrol-containing mouthwash could be used as an alternative to chlorhexidine as an adjunct to nonsurgical periodontal treatment of periodontitis.
Publikationsverlauf
Artikel online veröffentlicht:
09. September 2024
© 2024. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution License, permitting unrestricted use, distribution, and reproduction so long as the original work is properly cited. (https://creativecommons.org/licenses/by/4.0/)
Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, 2nd Floor, Sector 2, Noida-201301 UP, India
-
References
- 1 Slots J. Periodontitis: facts, fallacies and the future. Periodontol 2000 2017; 75 (01) 7-23
- 2 Balachandran S, Ganapathy D, Ramanathan V. Genetics as a risk factor in periodontitis-a review. Drug Invention Today 2019; 12 (10) 2270-2273
- 3 Mohammed MA, Abbas RF, Akram HM. Salivary IL-17 and IL-10 as potential diagnostic biomarkers of different stages of periodontitis in smoker and nonsmoker patients. Eur J Dent 2024; 18 (01) 253-264
- 4 Almeida-da-Silva CLC, Alpagot T, Zhu Y. et al. Chlamydia pneumoniae is present in the dental plaque of periodontitis patients and stimulates an inflammatory response in gingival epithelial cells. Microb Cell 2019; 6 (04) 197-208
- 5 Vitt A, Gustafsson A, Ramberg P, Slizen V, Kazeko LA, Buhlin K. Polyhexamethylene guanidine phosphate irrigation as an adjunctive to scaling and root planing in the treatment of chronic periodontitis. Acta Odontol Scand 2019; 77 (04) 290-295
- 6 Alkakhan W, Farrar N, Sikora V. et al. Statins modulate microenvironmental cues driving macrophage polarization in simulated periodontal inflammation. Cells 2023; 12 (15) 1961
- 7 Rajagopal A, Varghese J, Bhat V, Acharya V, Kamath V. Anti-infective efficacy of mechanical debridement with adjunctive modalities on clinical and cytokine parameters in treatment of chronic periodontitis: randomized controlled clinical trial. Eur J Dent 2024; 18 (02) 526-533
- 8 Buommino E, Scognamiglio M, Donnarumma G, Fiorentino A, D'Abrosca B. Recent advances in natural product-based anti-biofilm approaches to control infections. Mini Rev Med Chem 2014; 14 (14) 1169-1182
- 9 Ramesh A, Varghese SS, Doraiswamy JN, Malaiappan S. Herbs as an antioxidant arsenal for periodontal diseases. J Intercult Ethnopharmacol 2016; 5 (01) 92-96
- 10 Faisal Madhloom A, Bashir Hashim Al-Taweel F, Sha AM, Raad Abdulbaqi H. Antimicrobial effect of Moringa Oleifera L. and red pomegranate against clinically isolated Porphyromonas gingivalis: in vitro study. Arch Razi Inst 2022; 77 (04) 1405-1419
- 11 Hunter PM, Hegele RA. Functional foods and dietary supplements for the management of dyslipidaemia. Nat Rev Endocrinol 2017; 13 (05) 278-288
- 12 Borghi C, Cicero AF. Nutraceuticals with a clinically detectable blood pressure-lowering effect: a review of available randomized clinical trials and their meta-analyses. Br J Clin Pharmacol 2017; 83 (01) 163-171
- 13 Cicero AFG, Colletti A, Bajraktari G. et al. Lipid-lowering nutraceuticals in clinical practice: position paper from an International Lipid Expert Panel. Nutr Rev 2017; 75 (09) 731-767
- 14 Csiszar A, Labinskyy N, Olson S. et al. Resveratrol prevents monocrotaline-induced pulmonary hypertension in rats. Hypertension 2009; 54 (03) 668-675
- 15 Zhang H, Morgan B, Potter BJ. et al. Resveratrol improves left ventricular diastolic relaxation in type 2 diabetes by inhibiting oxidative/nitrative stress: in vivo demonstration with magnetic resonance imaging. Am J Physiol Heart Circ Physiol 2010; 299 (04) H985-H994
- 16 Fan E, Zhang L, Jiang S, Bai Y. Beneficial effects of resveratrol on atherosclerosis. J Med Food 2008; 11 (04) 610-614
- 17 Weiner GM, Ducruet AF. Resveratrol and pharmacological potentiation in ischemic stroke. Neurosurgery 2014; 74 (06) N17-N18
- 18 Baczko I, Liknes D, Yang W. et al. Characterization of a novel multifunctional resveratrol derivative for the treatment of atrial fibrillation. Br J Pharmacol 2014; 171 (01) 92-106
- 19 Aguirre L, Portillo MP, Hijona E, Bujanda L. Effects of resveratrol and other polyphenols in hepatic steatosis. World J Gastroenterol 2014; 20 (23) 7366-7380
- 20 Carter LG, D'Orazio JA, Pearson KJ. Resveratrol and cancer: focus on in vivo evidence. Endocr Relat Cancer 2014; 21 (03) R209-R225
- 21 Bremer AA. Resveratrol use in metabolic syndrome. Metab Syndr Relat Disord 2014; 12 (10) 493-495
- 22 Hu W, Yang E, Ye J, Han W, Du ZL. Resveratrol protects neuronal cells from isoflurane-induced inflammation and oxidative stress-associated death by attenuating apoptosis via Akt/p38 MAPK signaling. Exp Ther Med 2018; 15 (02) 1568-1573
- 23 Andrade EF, Orlando DR, Araújo AMS. et al. Can resveratrol treatment control the progression of induced periodontal disease? A systematic review and meta-analysis of preclinical studies. Nutrients 2019; 11 (05) 953
- 24 Kugaji MS, Kumbar VM, Peram MR, Patil S, Bhat KG, Diwan PV. Effect of Resveratrol on biofilm formation and virulence factor gene expression of Porphyromonas gingivalis in periodontal disease. APMIS 2019; 127 (04) 187-195
- 25 Zare Javid A, Hormoznejad R, Yousefimanesh HA. et al. The impact of resveratrol supplementation on blood glucose, insulin, insulin resistance, triglyceride, and periodontal markers in type 2 diabetic patients with chronic periodontitis. Phytother Res 2017; 31 (01) 108-114
- 26 Pelekanou V, Kampa M, Kiagiadaki F. et al. Estrogen anti-inflammatory activity on human monocytes is mediated through cross-talk between estrogen receptor ERα36 and GPR30/GPER1. J Leukoc Biol 2016; 99 (02) 333-347
- 27 Al-Taweel FB, Saliem SS, Abd OH, Whawell SA. Assessment of serum interleukin-1β and interleukin-6 levels in patients with chronic periodontitis and coronary heart disease. Eur J Gen Dent 2021; 10 (02) 78-83
- 28 Rizzo A, Bevilacqua N, Guida L, Annunziata M, Romano Carratelli C, Paolillo R. Effect of resveratrol and modulation of cytokine production on human periodontal ligament cells. Cytokine 2012; 60 (01) 197-204
- 29 Ebersole JL, Kirakodu S, Novak MJ. et al. Cytokine gene expression profiles during initiation, progression and resolution of periodontitis. J Clin Periodontol 2014; 41 (09) 853-861
- 30 Nolde M, Alayash Z, Reckelkamm SL. et al. Downregulation of interleukin 6 signaling might reduce the risk of periodontitis: a drug target Mendelian randomization study. Front Immunol 2023; 14: 1160148
- 31 Rudick CP, Lang MS, Miyamoto T. Understanding the pathophysiology behind chairside diagnostics and genetic testing for IL-1 and IL-6. Oral Dis 2019; 25 (08) 1879-1885
- 32 Tsukasaki M. RANKL and osteoimmunology in periodontitis. J Bone Miner Metab 2021; 39 (01) 82-90
- 33 Muhssin SA, Akram HM. Assessment of salivary levels of the RANKL and RANK in patients with healthy gingiva on reduced periodontium versus periodontitis: an analytical cross-sectional study. Dent Hypotheses 2023; 14 (02) 49-51
- 34 Ribeiro FV, Pino DS, Franck FC. et al. Resveratrol inhibits periodontitis-related bone loss in rats subjected to cigarette smoke inhalation. J Periodontol 2017; 88 (08) 788-798
- 35 Schlagenhauf U, Hess JV, Stölzel P, Haubitz I, Jockel-Schneider Y. Impact of a two-stage subgingival instrumentation scheme involving air polishing on attachment gain after active periodontal therapy. J Periodontol 2022; 93 (10) 1500-1509
- 36 Tonetti MS, Greenwell H, Kornman KS. Staging and grading of periodontitis: framework and proposal of a new classification and case definition. J Periodontol 2018; 89 (Suppl. 01) S159-S172
- 37 Türkoğlu O, Becerik S, Emingil G, Kütükçüler N, Baylas H, Atilla G. The effect of adjunctive chlorhexidine mouthrinse on clinical parameters and gingival crevicular fluid cytokine levels in untreated plaque-associated gingivitis. Inflamm Res 2009; 58 (05) 277-283
- 38 Beiswanger BB, Mallat ME, Jackson RD. et al. Clinical effects of a 0.12% chlorhexidine rinse as an adjunct to scaling and root planing. J Clin Dent 1992; 3 (02) 33-38
- 39 Singh S, Vandana KL. Stent as an accessory tool in periodontal measurements: an insight. J Indian Soc Periodontol 2019; 23 (01) 81-84
- 40 O'Leary TJ, Drake RB, Naylor JE. The plaque control record. J Periodontol 1972; 43 (01) 38
- 41 Newman MG, Takei H, Klokkevold PR, Carranza FA. Carranza's Clinical Periodontology. . Elsevier Health Sciences 2011
- 42 Navazesh MJAotNYAoS. Methods for collecting saliva. Ann N Y Acad Sci 1993; 694 (01) 72-77
- 43 Paraskevas S, Rosema NA, Versteeg P, Van der Velden U, Van der Weijden GA. Chlorine dioxide and chlorhexidine mouthrinses compared in a 3-day plaque accumulation model. J Periodontol 2008; 79 (08) 1395-1400
- 44 Abed SA, Ali BG, Mohsin HJ. Comparison between the effects of Aloe vera and chlorhexidine on clinical periodontal parameters. J Bagh Coll Dent 2019; 31 (04) 31-35
- 45 Fonseca DC, Cortelli JR, Cortelli SC. et al. Clinical and microbiologic evaluation of scaling and root planing per quadrant and one-stage full-mouth disinfection associated with azithromycin or chlorhexidine: a clinical randomized controlled trial. J Periodontol 2015; 86 (12) 1340-1351
- 46 Feres M, Gursky LC, Faveri M, Tsuzuki CO, Figueiredo LC. Clinical and microbiological benefits of strict supragingival plaque control as part of the active phase of periodontal therapy. J Clin Periodontol 2009; 36 (10) 857-867
- 47 Murakami S, Mealey BL, Mariotti A, Chapple ILC. Dental plaque-induced gingival conditions. J Clin Periodontol 2018; 45 (Suppl. 20) S17-S27
- 48 Grootveld M, Silwood C, Gill D, Lynch E. Evidence for the microbicidal activity of a chlorine dioxide-containing oral rinse formulation in vivo. J Clin Dent 2001; 12 (03) 67-70
- 49 Jenkins S, Addy M, Wade W. The mechanism of action of chlorhexidine. A study of plaque growth on enamel inserts in vivo. J Clin Periodontol 1988; 15 (07) 415-424
- 50 Khazaei S, Khazaei M, Kazemi S, Yaghini J. Resveratrol as a supplemental treatment for periodontitis. Dent Res J (Isfahan) 2012; 9 (05) 655-657
- 51 Park H-J, Jeong S-K, Kim S-R. et al. Resveratrol inhibits Porphyromonas gingivalis lipopolysaccharide-induced endothelial adhesion molecule expression by suppressing NF-kappaB activation. Arch Pharm Res 2009; 32 (04) 583-591
- 52 Berta GN, Romano F, Vallone R, Abbadessa G, Di Scipio F, Defabianis P. An innovative strategy for oral biofilm control in early childhood based on a resveratrol-cyclodextrin nanotechnology approach. Materials (Basel) 2021; 14 (14) 3801
- 53 Basu A, Masek E, Ebersole JL. Dietary polyphenols and periodontitis—a mini-review of literature. Molecules 2018; 23 (07) 1786
- 54 Shoukheba MYM. Effect of resveratrol as an antioxidant in the treatment of smokers patients with stage iii periodontitis. SAR J Dent Oral Surg Med 2020; 1 (01) 1-7
- 55 Tonguç MÖ, Öztürk O, Sütçü R. et al. The impact of smoking status on antioxidant enzyme activity and malondialdehyde levels in chronic periodontitis. J Periodontol 2011; 82 (09) 1320-1328
- 56 Varela-López A, Bullón P, Giampieri F, Quiles JL. Non-nutrient, naturally occurring phenolic compounds with antioxidant activity for the prevention and treatment of periodontal diseases. Antioxidants 2015; 4 (03) 447-481
- 57 Kupisiewicz K, Boissy P, Abdallah BM. et al. Potential of resveratrol analogues as antagonists of osteoclasts and promoters of osteoblasts. Calcif Tissue Int 2010; 87 (05) 437-449
- 58 Boissy P, Andersen TL, Abdallah BM, Kassem M, Plesner T, Delaissé JM. Resveratrol inhibits myeloma cell growth, prevents osteoclast formation, and promotes osteoblast differentiation. Cancer Res 2005; 65 (21) 9943-9952
- 59 Chin YT, Cheng GY, Shih YJ. et al. Therapeutic applications of resveratrol and its derivatives on periodontitis. Ann N Y Acad Sci 2017; 1403 (01) 101-108
- 60 Javid AZ, Hormoznejad R, Yousefimanesh HA, Haghighi-Zadeh MH, Zakerkish M. Impact of resveratrol supplementation on inflammatory, antioxidant, and periodontal markers in type 2 diabetic patients with chronic periodontitis. Diabetes Metab Syndr 2019; 13 (04) 2769-2774
- 61 Zhang Q, Xu S, Xu W, Zhou Y, Luan H, Wang D. Resveratrol decreases local inflammatory markers and systemic endotoxin in patients with aggressive periodontitis. Medicine (Baltimore) 2022; 101 (25) e29393
- 62 Bhattarai G, Poudel SB, Kook SH, Lee JC. Resveratrol prevents alveolar bone loss in an experimental rat model of periodontitis. Acta Biomater 2016; 29: 398-408
- 63 Zhen L, Fan DS, Zhang Y, Cao XM, Wang LM. Resveratrol ameliorates experimental periodontitis in diabetic mice through negative regulation of TLR4 signaling. Acta Pharmacol Sin 2015; 36 (02) 221-228
- 64 Tamaki N, Cristina Orihuela-Campos R, Inagaki Y, Fukui M, Nagata T, Ito HO. Resveratrol improves oxidative stress and prevents the progression of periodontitis via the activation of the Sirt1/AMPK and the Nrf2/antioxidant defense pathways in a rat periodontitis model. Free Radic Biol Med 2014; 75: 222-229
- 65 Cochran DL. Inflammation and bone loss in periodontal disease. J Periodontol 2008; 79 (8, Suppl): 1569-1576
- 66 Al-Ghurabi BH, Mohssen SM. Salivary level of RANKL and OPG in chronic periodontitis. J Bagh Coll Dent 2015; 27 (01) 189-194
- 67 Frank ME, Gent JF, Hettinger TP. Effects of chlorhexidine on human taste perception. Physiol Behav 2001; 74 (1–2): 85-99
- 68 Helms JA, Della-Fera MA, Mott AE, Frank ME. Effects of chlorhexidine on human taste perception. Arch Oral Biol 1995; 40 (10) 913-920
- 69 Roland WS, van Buren L, Gruppen H. et al. Bitter taste receptor activation by flavonoids and isoflavonoids: modeled structural requirements for activation of hTAS2R14 and hTAS2R39. J Agric Food Chem 2013; 61 (44) 10454-10466
- 70 Abdulkareem AA, Al Marah ZA, Abdulbaqi HR, Alshaeli AJ, Milward MR. A randomized double-blind clinical trial to evaluate the efficacy of chlorhexidine, antioxidant, and hyaluronic acid mouthwashes in the management of biofilm-induced gingivitis. Int J Dent Hyg 2020; 18 (03) 268-277
- 71 Marinone MG, Savoldi E. Chlorhexidine and taste. Influence of mouthwashes concentration and of rinsing time. Minerva Stomatol 2000; 49 (05) 221-226
- 72 Zhao L, Xu J, Li S. et al. Resveratrol alleviates salivary gland dysfunction induced by ovariectomy in rats. Biochem Biophys Res Commun 2022; 630: 112-117
- 73 Xu L, Yang X, Cai J. et al. Resveratrol attenuates radiation-induced salivary gland dysfunction in mice. Laryngoscope 2013; 123 (11) E23-E29
- 74 Şimşek G, Gürocak S, Karadaǧ N. et al. Protective effects of resveratrol on salivary gland damage induced by total body irradiation in rats. Laryngoscope 2012; 122 (12) 2743-2748
- 75 Stadler AF, Romagna R, Rossi V, Costa DM, Gomes SC. Self-perception of patients after periodontal treatment: a longitudinal study. Indian J Dent Res 2017; 28 (05) 519-523
- 76 Baiju RM, Peter E, Varghese NO, Anju P. Patient reported outcome assessment of periodontal therapy: a systematic review. J Clin Diagn Res 2017; 11 (08) ZC14-ZC19